| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| mogamulizumab trial | 0.85 | 0.7 | 5658 | 47 | 19 |
| mogamulizumab | 0.65 | 0.2 | 1421 | 76 | 13 |
| trial | 0.15 | 0.3 | 172 | 37 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| mogamulizumab treatment | 1.6 | 0.2 | 7097 | 88 |
| mogamulizumab and ecp | 1.11 | 1 | 3059 | 48 |
| mogamulizumab approval | 1.11 | 0.2 | 8380 | 45 |
| mogamulizumab associated rash | 1.35 | 1 | 4483 | 37 |
| mogamulizumab atopic dermatitis | 0.79 | 0.4 | 9981 | 7 |
| mogamulizumab atll | 0.6 | 0.4 | 5430 | 95 |
| mogamulizumab adcc | 0.6 | 1 | 2410 | 17 |
| mavoric trial mogamulizumab | 0.46 | 0.6 | 9688 | 82 |
